http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I717521-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d38f2ab0718abd0cb7ded079b6c5ad6 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14 |
| filingDate | 2017-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d72898e3e80a00395f65259521397e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cc5e47cbf331a3579f764108d272dfe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ffb4423e825f16edd2303a788515f01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_664ce1588aa9f3237b481e53d6c0a7b0 |
| publicationDate | 2021-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-I717521-B |
| titleOfInvention | A therapy for polyglutamine (polyq) diseases |
| abstract | Provided are methods and articles of manufacture for use in stem cell therapy, for the treatment of diseases or conditions of SCA. Particularly, the invention provides a method for treating SCA, comprising parenterally or locally administering an effective amount of stem cells as a unit dosage to a subject, wherein the administration is performed with one or more treatment cycles, wherein one treatment cycle comprises dosing three unit dosages each at a dosing interval of two to six weeks. |
| priorityDate | 2017-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 409.